New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
bluebird bio, Inc.
BLUE
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

98M

Biotechnology

Next Earning date - 05 Nov 2024

98M

Biotechnology

Next Earning date - 05 Nov 2024

0.50USD
Shape-0.00 ( -0.22%)
Market Open
favorite-chart

Relative Strenght

5
favorite-chart

Volume Buzz

-59%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

91%

Quote Panel

Shape
Updated October 14, 2024
1W 3.53 % 1M -12.69 % 3M -61.79 % 1Y -81.99 %

Key Metrics

Shape
  • Market Cap

    97.91M


  • Shares Outstanding

    193.91M


  • Share in Float

    192.36M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    0.5049


  • Average Volume

    7.59M


  • Beta

    0.795


  • Range

    0.45-5.53


  • Industry

    Biotechnology


  • Website

    https://www.bluebirdbio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.78x

P/S Ratio

1.85x

P/B Ratio

7.4

Debt/Equity

-567.3%

Net Margin

$-2.3

EPS

How BLUE compares to sector?

P/E Ratio

Relative Strength

Shape

BLUE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$248M

Shape1439%

2025-Revenue

$0.51

Shape-21%

2025-EPS

$248M

Shape-317%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Wedbush

upgrade

Previous: Neutral

2023-07-19

Now: Buy

Barclays

upgrade

Previous: Equal-Weight

2023-06-01

Now: Overweight

Barclays

upgrade

Previous: Not converted

2022-08-22

Now: Equal-Weight

Raymond James

upgrade

Previous: Not converted

2022-08-01

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.92
vs -2.93

Q4.22

arrow
arrow

+121%

0.38
vs -1.82

Q1.23

arrow
arrow

+113%

0.21
vs -1.66

Q2.23

arrow
arrow

N/A

-0.67
vs -1.29

Q3.23

arrow
arrow

N/A

-0.66
vs -0.92

Q4.23

arrow
arrow

-100%

NA
vs 0.38

Q1.24

arrow
arrow

N/A

0.21
vs 0.21

Q2.24

arrow
arrow

N/A

-0.78
vs -0.67

Q3.24

arrow
arrow

N/A

-0.36
vs -0.66

Q4.24

arrow
arrow

N/A

-0.29
vs NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-100%

71K  vs 22.7M

Q4.22

arrow
arrow

-96%

62K  vs 1.6M

Q1.23

arrow
arrow

+22%

2.4M  vs 1.9M

Q2.23

arrow
arrow

+354%

6.9M  vs 1.5M

Q3.23

arrow
arrow

+17354%

12.4M  vs 71K

Q4.23

arrow
arrow

+12535%

7.8M  vs 62K

Q1.24

arrow
arrow

+680%

18.6M  vs 2.4M

Q2.24

arrow
arrow

+134%

16.1M  vs 6.9M

Q3.24

arrow
arrow

+46%

18.1M  vs 12.4M

Q4.24

arrow
arrow

+256%

27.9M  vs 7.8M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-48%

-0.48
vs -0.52

Q4.22

arrow
arrow

+16%

0.16
vs -0.48

Q1.23

arrow
arrow

+10%

0.1
vs 0.16

Q2.23

arrow
arrow

-25%

-0.25
vs 0.1

Q3.23

arrow
arrow

-32%

-0.32
vs -0.25

Q4.23

arrow
arrow

-45%

-0.45
vs -0.32

Q1.24

arrow
arrow

-53%

-0.53
vs -0.45

Q2.24

arrow
arrow

-154%

-1.54
vs -0.53

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

168

168
vs 153

10%

Q4.22

arrow
arrow

194

194
vs 168

15%

Q1.23

arrow
arrow

186

186
vs 194

-4%

Q2.23

arrow
arrow

184

184
vs 186

-1%

Q3.23

arrow
arrow

174

174
vs 184

-5%

Q4.23

arrow
arrow

197

197
vs 174

13%

Q1.24

arrow
arrow

166

166
vs 197

-16%

Q2.24

arrow
arrow

154

154
vs 166

-7%

Earnings Growth

Latest News